South & Central America Wound Closure Device Market Analysis and Forecast by Size, Share, Growth, Trends 2031

South & Central America Wound Closure Devices Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Other Products), Wound Type (Chronic Wound and Acute Wound), and End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Other End Users)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031
  • Report Code : TIPRE00041363
  • Category : Life Sciences
  • No. of Pages : 157
  • Available Report Formats : pdf-format excel-format
South & Central America Wound Closure Device Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Report Date: Oct 2025   |   Report Code: TIPRE00041363
Buy Now

The South & Central America wound closure device market size is expected to reach US$ 387.35 million by 2031 from US$ 306.05 million in 2024. The market is estimated to record a CAGR of 3.4% from 2025-2031.

Executive Summary and South & Central America Wound Closure Device Market Analysis:

The South & Central America wound closure devices market is segmented into Brazil, Argentina, and the rest of South & Central America. The market growth in the region is driven by the increasing collaborations between public and private organizations and rising incidences of chronic wounds due to the prevalence of diabetes and other chronic diseases.

As life expectancy is increasing, the elderly population in countries such as Brazil, Argentina, and Mexico is growing, leading to a higher incidence of chronic diseases such as diabetes and cardiovascular diseases that often require surgical procedures. Older individuals are more susceptible to developing chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous ulcers, which require effective wound closure solutions for proper healing.

As chronic diseases become more prevalent, an increasing number of patients undergo surgeries, thereby boosting the demand for wound closure devices. Colombia, as part of the 19 countries in the IDF SACA region (South & Central America), has a significant diabetes burden. Globally, 537 million people are living with diabetes, with over 33 million individuals affected in the SACA region. By 2045, this number is projected to rise to 49 million. In Colombia, as of 2021, the total adult population stands at 34,882,800, with a diabetes prevalence rate of 9.9%; this means that approximately 3,443,600 adults in the country are living with diabetes.

Countries such as Brazil and Colombia are making significant investments to modernize and expand their healthcare systems. For example, Brazil's "More Doctors Program" effectively expands access to healthcare and improves service quality. These reforms include building new hospitals, upgrading existing healthcare facilities, and enhancing the training of healthcare professionals.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

South & Central America Wound Closure Devices Market: Strategic Insights

south-and-central-america-wound-closure-device-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

South & Central America Wound Closure Device Market Segmentation Analysis:

Key segments that contributed to the derivation of the wound closure device market analysis are product, wound type, and end use.

  • By product, the wound closure device market is segmented into sutures, adhesives, staplers, strips, and others. The sutures segment held the largest share of the market in 2024.
  • By wound type, the wound closure device market is bifurcated into chronic wound and acute wound. The chronic wound segment held a larger share of the market in 2024.
  • By end use, the wound closure device market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2024.

South & Central America Wound Closure Devices Market Report Scope

Report Attribute Details
Market size in 2024 US$ 306.05 Million
Market Size by 2031 US$ 387.35 Million
CAGR (2025 - 2031) 3.4%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Sutures
  • Staplers
  • Adhesives
  • Strips
  • Others
By Wound Type
  • Chronic Wound
  • Acute Wound
By End Use
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
Regions and Countries Covered South & Central America
  • Brazil
  • Argentina
  • Rest of South & Central America
Market leaders and key company profiles
  • B Braun SE
  • Johnson & Johnson
  • Medtronic Plc
  • 3M Co
  • Stryker Corp
  • Baxter International Inc
  • Meril Life Sciences Pvt Ltd
  • CooperSurgical, Inc
  • Smith & Nephew Plc
  • TI Medical
  • Futura Surgicare Pvt Ltd (Dolphin Sutures)
  • Corza Medical GmbH
  • Essity AB
  • Advanced Medical Solutions Group plc
  • Healthium Medtech Limited

South & Central America Wound Closure Devices Market Players Density: Understanding Its Impact on Business Dynamics

The South & Central America Wound Closure Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

south-and-central-america-wound-closure-device-market-cagr

South & Central America Wound Closure Device Market Outlook

Noncommunicable diseases (NCDs) or chronic diseases, such as heart disease, stroke, cancer, diabetes, and chronic lung disease, account for 74% of all deaths worldwide. Over three-quarters of NCD-related deaths, and 86% of the 17 million people who die before reaching 70 years of age, occur in low- and middle-income countries.

The growing number of chronic diseases, including diabetes and cardiovascular diseases, is a major opportunity for the wound closure devices market. Chronic diseases tend to cause complications that may necessitate surgeries or prolonged wound care. For instance, diabetic patients are likely to develop chronic wounds, including diabetic ulcers, which require appropriate care and closure devices for healing. The number of people living with diabetes rose by 830 million in 2022 from 200 million in 1990. The prevalence is growing more rapidly in low- and middle-income nations compared to high-income countries.

Moreover, the increasing number of trauma cases such as burns, accidents, and injuries is fueling the increased demand for effective wound care solutions. Trauma is a major global health issue, resulting in approximately 5.8 million deaths and 40 million permanent injuries each year. Nearly 90% of these fatalities occur in low- and middle-income countries. Common causes of trauma include road traffic accidents, falls, workplace injuries, and violence. This issue disproportionately affects younger populations and imposes a crucial economic burden due to lost productivity and healthcare costs.

Wound closure devices are needed to treat these conditions, providing quicker healing, minimizing infection risk, and enhancing overall patient outcomes. With a growing population of older people who are more susceptible to chronic conditions and a rise in the incidence of trauma cases, healthcare professionals prefer sophisticated wound closure solutions to meet these demands. The synergy between technological innovation, including the creation of specialized wound care products, and the demand for quicker recovery solutions creates a significant growth opportunity for the market. Producers that emphasize innovations specific to chronic wounds and trauma will likely account for a greater percentage of the market since the demand for successful wound treatment will keep growing around the world.

South & Central America Wound Closure Device Market Country Insights

Based on country, the South & Central America wound closure device market comprises Argentina, Brazil, and the Rest of South & Central America. Brazil held the largest share in 2024.

The healthcare system in Brazil is highly regarded for its offerings in medical tourism. Additionally, Brazil is recognized as a leading destination for world-class aesthetic treatments. Further, the availability of treatments for DFU and pressure ulcers is notably extensive. Companies are collaborating with organizations to introduce their products in Brazil. In November 2019, SANUWAVE Health, Inc. entered into an agreement with IDIC Group based in Sao Paulo, Brazil, granting exclusive rights to its product, "dermaPACE," designed for the treatment of chronic wounds. In August 2020, SANUWAVE Health, Inc. obtained approval from the National Health Surveillance Agency for its patented dermaPACE System, which is specifically aimed at treating diabetic foot ulcers. International companies are expanding their businesses across Brazil. Mölnlycke Health Care AB has initiated its expansion in Brazil, China, and the Middle East by developing its sales and marketing.

South & Central America Wound Closure Devices Market Company Profiles

Some of the key players operating in the market include Healthium Medtech Limited, Advanced Medical Solutions Group plc, Essity AB, Corza Medical GmbH, Futura Surgicare Pvt Ltd (Dolphin Sutures), TI Medical, Smith & Nephew Plc, CooperSurgical, Inc, Meril Life Sciences Pvt Ltd, Baxter International Inc, Stryker Corp, 3M Co, Medtronic Plc, Johnson & Johnson, and B Braun SE, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South & Central America Wound Closure Device Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations.
  • Industry trade journals and other relevant publications.
  • Government documents, statistical databases, and market reports.
  • News articles, press releases, and webcasts specific to companies operating in the market.

Note:

All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research.
  • Enhance the expertise and market understanding of the analysis team.
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA
Page Updated: Dec 2025